TriSalus Life Sciences, Inc.

MedTech Acquisition Corp, filing under the name TriSalus Life Sciences, Inc. and ticker MTAC, is a healthcare-focused blank-check company that completed its IPO in 2020, sponsored by MedTech Acquisition Sponsor LLC. In May 2021, the SPAC announced a definitive agreement to merge with TriSalus Life Sciences, a privately held medical device company developing pressure-enabled drug delivery systems targeting liver and pancreatic cancers. The June 2021 10-Q filing reflects the entity mid-transaction, ahead of shareholder approval. The business combination ultimately closed in 2022, with the company relisting under the ticker TLSI on Nasdaq. To access full filing histories, deal analytics, and sponsor intelligence on MTAC and the broader SPAC universe, sign up for full data at SpacDesk.